We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.

Skip to main content

The Jackson Laboratory

Home

Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
Human iPS Cells
June 2025 Preview iPSC lines in development

June 2025 Preview iPSC lines in development

Published Date June 18, 2025

Download PDF

Previous Video

Unlocking Insights with JAX's iPSCs: Rigorous Quality Control and Characterization to Accelerate Breakthroughs

This webinar is an exclusive behind-the-scenes look at JAX’s precise genetic engineering and high-throughput characterization of our human induced pluripotent stem cell (iPSC) lines.
Next Video

JAX Tech Talk Episode 68: Let’s Talk iPSC Disease Models as a Tool in Drug Discovery (Nov. 7, 2023)

During this JAX Tech Talk, Dr. Steven Rodriguez, Lab Head of the Rare & Neurological Diseases Therapeutic Area at Sanofi, discusses how his group uses iPSC models to understand disease biology.

Other content in this Stream

about 1 year ago
Unlocking Insights with JAX's iPSCs: Rigorous Quality Control and Characterization to Accelerate Breakthroughs

This webinar is an exclusive behind-the-scenes look at JAX’s precise genetic engineering and high-throughput characterization of our human induced pluripotent stem cell (iPSC) lines.

Watch Video
over 1 year ago
JAX Tech Talk Episode 68: Let’s Talk iPSC Disease Models as a Tool in Drug Discovery (Nov. 7, 2023)

During this JAX Tech Talk, Dr. Steven Rodriguez, Lab Head of the Rare & Neurological Diseases Therapeutic Area at Sanofi, discusses how his group uses iPSC models to understand disease biology.

Watch Video
over 2 years ago
JAX Tech Talk Episode 59: Let’s Talk iPSCs and Their Value in Tackling Neurodegenerative Diseases (Sep. 20, 2022)

Dr. Mark Cookson talks about the unique aspects of the collection of human isogenic iPSC lines and how it can benefit the wider scientific community in their shared quest to understand and fight ADRD.

Watch Video
about 5 years ago
Moving beyond amyloid to treat Alzheimer's disease

Beta-amyloid peptid. The amyloid precursor protein being cleaved by gamma and beta secretases and releasing the amyloid beta peptide, which can accumulate to amyloid plaques, one of the main...

Learn More
over 9 years ago
Alzheimer's disease and the complex puzzle of degeneration

Alzheimer’s disease is frightening. Incurable, progressive, burdensome and still biologically mysterious, it afflicts primarily the elderly and inexorably degenerates the brain tissue of patients....

Learn More

Return to Home